ConforMIS Stock Price, News & Analysis (NASDAQ:CFMS)

$1.40 -0.02 (-1.41 %)
(As of 02/23/2018 11:43 AM ET)
Previous Close$1.40
Today's Range$1.37 - $1.49
52-Week Range$1.15 - $5.98
Volume545,300 shs
Average Volume796,928 shs
Market Capitalization$83.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.41

About ConforMIS (NASDAQ:CFMS)

ConforMIS logoConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Receive CFMS News and Ratings via Email

Sign-up to receive the latest news and ratings for CFMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CFMS
CUSIPN/A
Phone781-345-9001

Debt

Debt-to-Equity Ratio0.52%
Current Ratio6.19%
Quick Ratio5.38%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$78.11 million
Price / Sales1.05
Cash FlowN/A
Price / CashN/A
Book Value$2.17 per share
Price / Book0.65

Profitability

Trailing EPS($1.24)
Net Income$-53,580,000.00
Net Margins-68.59%
Return on Equity-78.44%
Return on Assets-48.10%

Miscellaneous

Employees387
Outstanding Shares58,860,000

ConforMIS (NASDAQ:CFMS) Frequently Asked Questions

What is ConforMIS's stock symbol?

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

How were ConforMIS's earnings last quarter?

ConforMIS Inc (NASDAQ:CFMS) issued its quarterly earnings data on Wednesday, February, 7th. The medical instruments supplier reported ($0.27) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.30) by $0.03. The medical instruments supplier had revenue of $20.80 million for the quarter, compared to the consensus estimate of $20.07 million. ConforMIS had a negative net margin of 68.59% and a negative return on equity of 78.44%. ConforMIS's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period last year, the firm posted ($0.37) EPS. View ConforMIS's Earnings History.

When will ConforMIS make its next earnings announcement?

ConforMIS is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for ConforMIS.

Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2018?

7 Wall Street analysts have issued 1-year price targets for ConforMIS's stock. Their forecasts range from $4.00 to $7.50. On average, they anticipate ConforMIS's stock price to reach $4.75 in the next twelve months. View Analyst Ratings for ConforMIS.

Are investors shorting ConforMIS?

ConforMIS saw a decline in short interest during the month of January. As of January 31st, there was short interest totalling 1,750,599 shares, a decline of 30.3% from the January 12th total of 2,511,764 shares. Based on an average daily trading volume, of 1,295,167 shares, the short-interest ratio is presently 1.4 days. Currently, 5.2% of the company's shares are short sold.

Who are some of ConforMIS's key competitors?

Who are ConforMIS's key executives?

ConforMIS's management team includes the folowing people:

  • Kenneth Fallon III, Independent Chairman of the Board (Age 77)
  • Mark A. Augusti, President, Chief Executive Officer, Director (Age 51)
  • Paul S. Weiner, Chief Financial Officer (Age 53)
  • Dan Krupp, Senior Vice President - U.S. Sales
  • Daniel Steines M.D., Chief Technology Officer (Age 48)
  • David Cerveny, Chief Legal Officer and General Counsel (Age 50)
  • Philipp Lang M.D., Director (Age 54)
  • Bradley R. Langdale, Independent Director (Age 52)
  • Colm C. Lanigan, Independent Director (Age 51)
  • Richard J. Meelia, Independent Director (Age 68)

When did ConforMIS IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who owns ConforMIS stock?

ConforMIS's stock is owned by a number of of institutional and retail investors. Top institutional investors include Prosight Management LP (0.68%), ARK Investment Management LLC (0.66%), Renaissance Technologies LLC (0.59%), Bank of New York Mellon Corp (0.22%), Deutsche Bank AG (0.21%) and Spark Investment Management LLC (0.20%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Mark A Augusti, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.

Who sold ConforMIS stock? Who is selling ConforMIS stock?

ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc. and Bank of New York Mellon Corp. Company insiders that have sold ConforMIS company stock in the last year include Bradley Langdale, Daniel Steines, David Cerveny, Mark A Augusti, Paul S Weiner and Philipp Lang. View Insider Buying and Selling for ConforMIS.

Who bought ConforMIS stock? Who is buying ConforMIS stock?

ConforMIS's stock was bought by a variety of institutional investors in the last quarter, including Prosight Management LP, Renaissance Technologies LLC, ARK Investment Management LLC, Spark Investment Management LLC, Two Sigma Investments LP and Deutsche Bank AG. View Insider Buying and Selling for ConforMIS.

How do I buy ConforMIS stock?

Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ConforMIS's stock price today?

One share of ConforMIS stock can currently be purchased for approximately $1.40.

How big of a company is ConforMIS?

ConforMIS has a market capitalization of $83.58 million and generates $78.11 million in revenue each year. The medical instruments supplier earns $-53,580,000.00 in net income (profit) each year or ($1.24) on an earnings per share basis. ConforMIS employs 387 workers across the globe.

How can I contact ConforMIS?

ConforMIS's mailing address is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. The medical instruments supplier can be reached via phone at 781-345-9001 or via email at [email protected]


MarketBeat Community Rating for ConforMIS (CFMS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  189 (Vote Outperform)
Underperform Votes:  160 (Vote Underperform)
Total Votes:  349
MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ConforMIS (NASDAQ:CFMS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.432.332.402.43
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.75$5.70$6.13$8.25
Price Target Upside: 241.73% upside120.08% upside73.02% upside120.00% upside

ConforMIS (NASDAQ:CFMS) Consensus Price Target History

Price Target History for ConforMIS (NASDAQ:CFMS)

ConforMIS (NASDAQ:CFMS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/21/2018CowenInitiated CoverageOutperform$1.39 -> $4.00HighView Rating Details
2/8/2018Canaccord GenuityLower Price TargetHold -> Hold$5.00 -> $4.00MediumView Rating Details
2/8/2018OppenheimerSet Price TargetBuy$4.00MediumView Rating Details
1/10/2018BTIG ResearchReiterated RatingBuy$4.00LowView Rating Details
1/2/2018JPMorgan Chase & Co.DowngradeNeutral -> UnderweightMediumView Rating Details
8/4/2017Deutsche BankReiterated RatingBuy -> Hold$6.00 -> $5.00HighView Rating Details
5/16/2017B. RileyReiterated RatingBuy$7.50LowView Rating Details
9/19/2016SunTrust BanksInitiated CoverageBuy$14.00N/AView Rating Details
5/13/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

ConforMIS (NASDAQ:CFMS) Earnings History and Estimates Chart

Earnings by Quarter for ConforMIS (NASDAQ:CFMS)

ConforMIS (NASDAQ CFMS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018($0.27)N/AView Earnings Details
2/7/2018Q4 2017($0.30)($0.27)$20.07 million$20.80 millionViewListenView Earnings Details
11/1/2017Q3 2017($0.32)($0.29)$17.55 million$18.40 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.36)($0.28)$19.34 million$18.50 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.36)($0.40)$18.48 million$20.50 millionViewN/AView Earnings Details
2/15/2017Q416($0.30)($0.37)$21.37 million$21.70 millionViewListenView Earnings Details
11/3/2016Q316($0.36)($0.31)$18.27 million$18.60 millionViewListenView Earnings Details
8/8/2016Q216($0.35)($0.34)$18.02 million$19.30 millionViewListenView Earnings Details
5/12/2016Q116($0.38)($0.37)$19.23 million$20.30 millionViewListenView Earnings Details
2/11/2016Q415($0.41)($0.37)$17.23 million$19.10 millionViewListenView Earnings Details
11/2/2015Q3($0.38)($0.45)$13.51 million$13.90 millionViewN/AView Earnings Details
8/11/2015Q215($1.31)($2.51)$11.20 million$19.20 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

ConforMIS (NASDAQ:CFMS) Earnings Estimates

2018 EPS Consensus Estimate: ($1.03)
2019 EPS Consensus Estimate: ($0.64)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183($0.34)($0.24)($0.28)
Q2 20183($0.34)($0.21)($0.26)
Q3 20183($0.34)($0.20)($0.25)
Q4 20183($0.34)($0.17)($0.24)
Q1 20191($0.17)($0.17)($0.17)
Q2 20191($0.16)($0.16)($0.16)
Q3 20191($0.16)($0.16)($0.16)
Q4 20191($0.15)($0.15)($0.15)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for ConforMIS (NASDAQ:CFMS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

ConforMIS (NASDAQ CFMS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 23.19%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)

ConforMIS (NASDAQ CFMS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/6/2018Daniel SteinesInsiderSell3,632$1.30$4,721.60142,963View SEC Filing  
2/6/2018Paul S WeinerCFOSell2,674$1.30$3,476.20157,009View SEC Filing  
2/6/2018Philipp LangDirectorSell3,737$1.30$4,858.10590,375View SEC Filing  
12/19/2017David CervenyInsiderSell5,478$2.27$12,435.06152,073View SEC Filing  
12/19/2017Mark A AugustiCEOSell16,548$2.27$37,563.96285,007View SEC Filing  
12/19/2017Paul S WeinerCFOSell7,433$2.27$16,872.91167,116View SEC Filing  
12/5/2017Mark A AugustiCEOSell4,189$2.68$11,226.52236,163View SEC Filing  
11/15/2017Daniel SteinesCTOSell15,485$3.15$48,777.75254,652View SEC Filing  
11/15/2017David CervenyInsiderSell16,392$3.17$51,962.64151,408View SEC Filing  
11/15/2017Paul S WeinerCFOSell17,723$3.17$56,181.91162,009View SEC Filing  
10/18/2017Daniel SteinesCTOSell907$3.51$3,183.57254,652View SEC Filing  
10/18/2017Philipp LangDirectorSell1,839$3.53$6,491.67594,112View SEC Filing  
6/20/2017Bradley LangdaleDirectorSell6,722$4.30$28,904.6026,533View SEC Filing  
4/26/2017Daniel SteinesInsiderSell5,000$5.54$27,700.00190,745View SEC Filing  
4/5/2017Daniel SteinesInsiderSell5,000$5.00$25,000.00195,745View SEC Filing  
2/15/2017Philipp LangDirectorSell137,968$8.60$1,186,524.80558,759View SEC Filing  
2/3/2017David CervenyInsiderSell3,569$8.59$30,657.7187,501View SEC Filing  
2/3/2017Paul S WeinerCFOSell2,676$8.42$22,531.9282,115View SEC Filing  
2/3/2017Philipp LangDirectorSell108,705$8.60$934,863.00519,411View SEC Filing  
1/25/2017Philipp LangDirectorSell108,985$8.60$937,271.00558,153View SEC Filing  
1/23/2017Philipp LangDirectorSell9,681$8.60$83,256.60519,784View SEC Filing  
1/13/2017Philipp LangDirectorSell37,275$8.60$320,565.00514,769View SEC Filing  
1/11/2017Philipp LangDirectorSell2,800$8.62$24,136.00516,019View SEC Filing  
1/10/2017Philipp LangDirectorSell83,909$8.64$724,973.76516,119View SEC Filing  
1/9/2017Philipp LangDirectorSell6,200$8.65$53,630.00516,119View SEC Filing  
1/5/2017Philipp LangDirectorSell400$8.60$3,440.00514,719View SEC Filing  
1/3/2017Philipp LangDirectorSell74,876$8.00$599,008.00589,495View SEC Filing  
12/30/2016Philipp LangDirectorSell168,734$8.25$1,392,055.50547,639View SEC Filing  
12/28/2016Philipp LangDirectorSell58,547$8.26$483,598.22532,981View SEC Filing  
12/27/2016Philipp LangDirectorSell42,086$8.57$360,677.02520,939View SEC Filing  
12/23/2016Philipp LangDirectorSell30,647$8.62$264,177.14520,939View SEC Filing  
10/17/2016Daniel SteinesInsiderSell889$8.64$7,680.96214,324View SEC Filing  
10/17/2016Paul S WeinerCFOSell884$8.60$7,602.4084,791View SEC Filing  
10/12/2016Daniel SteinesInsiderSell10,000$9.66$96,600.00215,213View SEC Filing  
10/5/2016Philipp LangCEOSell53,860$10.19$548,833.40483,378View SEC Filing  
10/4/2016Philipp LangCEOSell400$10.00$4,000.00483,378View SEC Filing  
10/3/2016Daniel SteinesCTOSell10,000$10.03$100,300.00225,213View SEC Filing  
10/3/2016Philipp LangCEOSell10,410$10.03$104,412.30483,378View SEC Filing  
9/16/2016Daniel SteinesInsiderSell30,000$9.09$272,700.00245,213View SEC Filing  
8/17/2016Kenneth P Fallon IIIDirectorSell4,000$8.44$33,760.0092,222View SEC Filing  
5/17/2016Robert Law IIISVPBuy1,600$6.20$9,920.0024,793View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

ConforMIS (NASDAQ CFMS) News Headlines

Source:
DateHeadline
ConforMIS (CFMS) Coverage Initiated by Analysts at CowenConforMIS (CFMS) Coverage Initiated by Analysts at Cowen
www.americanbankingnews.com - February 21 at 10:59 AM
ConforMIS Inc (CFMS) Expected to Announce Quarterly Sales of $19.51 MillionConforMIS Inc (CFMS) Expected to Announce Quarterly Sales of $19.51 Million
www.americanbankingnews.com - February 20 at 11:44 AM
Zacks: Brokerages Anticipate ConforMIS Inc (CFMS) to Announce -$0.25 Earnings Per ShareZacks: Brokerages Anticipate ConforMIS Inc (CFMS) to Announce -$0.25 Earnings Per Share
www.americanbankingnews.com - February 18 at 5:08 AM
Active-Investors: Blog Exposure - Becton, Dickinsons New HPV Test BD Onclarity HPV Assay Gets FDA ApprovalActive-Investors: Blog Exposure - Becton, Dickinson's New HPV Test BD Onclarity HPV Assay Gets FDA Approval
www.finanznachrichten.de - February 15 at 5:33 PM
Blog Exposure - Becton, Dickinson’s New HPV Test BD Onclarity(TM) HPV Assay Gets FDA ApprovalBlog Exposure - Becton, Dickinson’s New HPV Test BD Onclarity(TM) HPV Assay Gets FDA Approval
finance.yahoo.com - February 15 at 7:42 AM
ConforMIS Inc (CFMS) Given Consensus Recommendation of "Hold" by BrokeragesConforMIS Inc (CFMS) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 13 at 11:20 AM
Zacks Investment Research Upgrades ConforMIS (CFMS) to HoldZacks Investment Research Upgrades ConforMIS (CFMS) to Hold
www.americanbankingnews.com - February 12 at 7:18 PM
Brokers Set Expectations for ConforMIS Incs FY2018 Earnings (CFMS)Brokers Set Expectations for ConforMIS Inc's FY2018 Earnings (CFMS)
www.americanbankingnews.com - February 12 at 6:36 AM
ConforMIS Inc (CFMS) Short Interest Down 30.3% in JanuaryConforMIS Inc (CFMS) Short Interest Down 30.3% in January
www.americanbankingnews.com - February 12 at 4:32 AM
SunTrust Banks Brokers Increase Earnings Estimates for ConforMIS Inc (CFMS)SunTrust Banks Brokers Increase Earnings Estimates for ConforMIS Inc (CFMS)
www.americanbankingnews.com - February 12 at 2:52 AM
ConforMIS Inc (CFMS) Forecasted to Post Q1 2018 Earnings of ($0.24) Per ShareConforMIS Inc (CFMS) Forecasted to Post Q1 2018 Earnings of ($0.24) Per Share
www.americanbankingnews.com - February 9 at 8:52 AM
Oppenheimer Analysts Give ConforMIS (CFMS) a $4.00 Price TargetOppenheimer Analysts Give ConforMIS (CFMS) a $4.00 Price Target
www.americanbankingnews.com - February 8 at 11:14 PM
Should ConforMIS Inc’s (NASDAQ:CFMS) Recent Earnings Worry You?Should ConforMIS Inc’s (NASDAQ:CFMS) Recent Earnings Worry You?
finance.yahoo.com - February 8 at 3:30 PM
ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial GuidanceConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance
finance.yahoo.com - February 8 at 3:30 PM
ConforMIS (CFMS) PT Lowered to $4.00ConforMIS (CFMS) PT Lowered to $4.00
www.americanbankingnews.com - February 8 at 1:30 PM
ConforMIS (CFMS) Announces  Earnings Results, Beats Estimates By $0.03 EPSConforMIS (CFMS) Announces Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - February 8 at 9:56 AM
ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance - GlobeNewswire (press release)ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance - GlobeNewswire (press release)
globenewswire.com - February 8 at 7:30 AM
ConforMIS (CFMS) CEO Mark Augusti on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaConforMIS' (CFMS) CEO Mark Augusti on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 8 at 7:30 AM
ConforMIS (CFMS) Scheduled to Post Quarterly Earnings on TuesdayConforMIS (CFMS) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 6 at 3:12 AM
ConforMIS Inc (CFMS) Prices 13.33M Shares Common Offering at $1.50/Sh - StreetInsider.comConforMIS Inc (CFMS) Prices 13.33M Shares Common Offering at $1.50/Sh - StreetInsider.com
www.streetinsider.com - January 27 at 7:31 AM
ConforMIS Inc (CFMS) Prices 13.33M Shares Common Offering at $1.50/ShConforMIS Inc (CFMS) Prices 13.33M Shares Common Offering at $1.50/Sh
www.streetinsider.com - January 26 at 3:31 PM
BRIEF-Conformis Announces Pricing Of Public Offering Of Common StockBRIEF-Conformis Announces Pricing Of Public Offering Of Common Stock
www.reuters.com - January 25 at 3:32 PM
ConforMISs stock plunges on heavy volume after stock offering prices at deep discountConforMIS's stock plunges on heavy volume after stock offering prices at deep discount
finance.yahoo.com - January 25 at 3:32 PM
ConforMIS Announces Pricing of Public Offering of Common StockConforMIS Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 25 at 3:32 PM
ConforMIS Inc (CFMS) Announces Proposed Common Share OfferingConforMIS Inc (CFMS) Announces Proposed Common Share Offering
www.streetinsider.com - January 25 at 7:36 AM
ConforMIS Announces Proposed Public Offering of Common StockConforMIS Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 25 at 7:36 AM
Zacks Investment Research Lowers ConforMIS (CFMS) to SellZacks Investment Research Lowers ConforMIS (CFMS) to Sell
www.americanbankingnews.com - January 24 at 8:00 PM
ConforMIS Inc (CFMS) Given Average Recommendation of "Hold" by AnalystsConforMIS Inc (CFMS) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - January 19 at 8:02 AM
ConforMIS (CFMS) Receives Buy Rating from BTIG ResearchConforMIS (CFMS) Receives Buy Rating from BTIG Research
www.americanbankingnews.com - January 10 at 7:40 AM
ConforMIS Inc (CFMS) Reports Prelim. 4Q & FY17 Revenues Above Consensus; Offers FY18 Revenue Guidance Below EstimatesConforMIS Inc (CFMS) Reports Prelim. 4Q & FY17 Revenues Above Consensus; Offers FY18 Revenue Guidance Below Estimates
www.streetinsider.com - January 9 at 9:33 AM
ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial GuidanceConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance
finance.yahoo.com - January 8 at 5:24 PM
ConforMIS Inc (CFMS) Says Results Published in Journal of Knee Surgery Show 100% of Patients Treated with iTotal ... - StreetInsider.comConforMIS Inc (CFMS) Says Results Published in Journal of Knee Surgery Show 100% of Patients Treated with iTotal ... - StreetInsider.com
www.streetinsider.com - January 5 at 5:04 PM
ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%
finance.yahoo.com - January 4 at 5:19 PM
JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans - BenzingaJPMorgan Diagnoses The MedTech Space: Stock Picks And Pans - Benzinga
www.benzinga.com - January 2 at 6:40 PM
 Brokerages Expect ConforMIS Inc (CFMS) Will Post Earnings of -$0.30 Per Share Brokerages Expect ConforMIS Inc (CFMS) Will Post Earnings of -$0.30 Per Share
www.americanbankingnews.com - December 29 at 11:48 AM
ETFs with exposure to ConforMIS, Inc. : December 26, 2017ETFs with exposure to ConforMIS, Inc. : December 26, 2017
finance.yahoo.com - December 28 at 1:36 PM
ConforMIS Inc (CFMS) Receives Average Recommendation of "Hold" from AnalystsConforMIS Inc (CFMS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 25 at 8:06 AM
Paul S. Weiner Sells 7,433 Shares of ConforMIS Inc (CFMS) StockPaul S. Weiner Sells 7,433 Shares of ConforMIS Inc (CFMS) Stock
www.americanbankingnews.com - December 20 at 11:34 PM
David Cerveny Sells 5,478 Shares of ConforMIS Inc (CFMS) StockDavid Cerveny Sells 5,478 Shares of ConforMIS Inc (CFMS) Stock
www.americanbankingnews.com - December 20 at 11:34 PM
Mark A. Augusti Sells 16,548 Shares of ConforMIS Inc (CFMS) StockMark A. Augusti Sells 16,548 Shares of ConforMIS Inc (CFMS) Stock
www.americanbankingnews.com - December 20 at 11:34 PM
ConforMIS (CFMS) Upgraded at BTIG ResearchConforMIS (CFMS) Upgraded at BTIG Research
www.americanbankingnews.com - December 20 at 12:56 PM
What Investors Should Know About ConforMIS Inc’s (NASDAQ:CFMS) Financial StrengthWhat Investors Should Know About ConforMIS Inc’s (NASDAQ:CFMS) Financial Strength
finance.yahoo.com - December 19 at 5:18 PM
Head-To-Head Review: ConforMIS (CFMS) and Cerus (CERS)Head-To-Head Review: ConforMIS (CFMS) and Cerus (CERS)
www.americanbankingnews.com - December 16 at 1:52 AM
ETFs with exposure to ConforMIS, Inc. : December 15, 2017ETFs with exposure to ConforMIS, Inc. : December 15, 2017
finance.yahoo.com - December 15 at 5:54 PM
 Analysts Anticipate ConforMIS Inc (CFMS) Will Announce Quarterly Sales of $19.95 Million Analysts Anticipate ConforMIS Inc (CFMS) Will Announce Quarterly Sales of $19.95 Million
www.americanbankingnews.com - December 14 at 12:30 PM
Contrasting ConforMIS (CFMS) & Its PeersContrasting ConforMIS (CFMS) & Its Peers
www.americanbankingnews.com - December 7 at 9:38 PM
Head-To-Head Survey: ConforMIS (CFMS) versus Its CompetitorsHead-To-Head Survey: ConforMIS (CFMS) versus Its Competitors
www.americanbankingnews.com - December 7 at 1:22 AM
ConforMIS (CFMS) versus Its Competitors Head to Head SurveyConforMIS (CFMS) versus Its Competitors Head to Head Survey
www.americanbankingnews.com - December 6 at 11:30 PM
ConforMIS Inc (CFMS) CEO Sells $11,226.52 in StockConforMIS Inc (CFMS) CEO Sells $11,226.52 in Stock
www.americanbankingnews.com - December 6 at 9:26 PM
ETFs with exposure to ConforMIS, Inc. : December 5, 2017ETFs with exposure to ConforMIS, Inc. : December 5, 2017
finance.yahoo.com - December 5 at 5:15 PM

SEC Filings

ConforMIS (NASDAQ:CFMS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ConforMIS (NASDAQ:CFMS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ConforMIS (NASDAQ CFMS) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.